| Jacob Donald Bailey, MD | |
|
130 White Sage Ave, Delta, UT 84624-8928 | |
| (435) 864-2708 | |
| (435) 864-2855 |
| Full Name | Jacob Donald Bailey |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 130 White Sage Ave, Delta, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396275434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 127-T2 (Wyoming) | Secondary |
| 207Q00000X | Family Medicine | 7351942-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Delta Community Hospital | Delta, UT | Hospital |
| Utah Valley Hospital | Provo, UT | Hospital |
| Millard County Care And Rehabilitation | Delta, UT | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Interventions that target individuals with a high risk of contracting HIV have a negligible impact on HIV transmission in the general population, according to a new study of communities in Zimbabwe, published today.
Recently, a team of researchers from the King's College London, Guy's and St Thomas' NHS Foundation Trust, and St Thomas' Hospital, London analyzed comprehensive epidemiological and viral nanopore sequence data from 574 patients with SARS-CoV-2 infection confirmed by a PCR test in March 2020.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $754,000 from the closing of the third and final tranche of a non-brokered private placement of 430,713 units priced at $1.75 per Unit.
A new public-private partnership between the National Science Foundation (NSF), National Cancer Institute (NCI), Stand Up To Cancer (SU2C) and The V Foundation for Cancer Research is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Interventions that target individuals with a high risk of contracting HIV have a negligible impact on HIV transmission in the general population, according to a new study of communities in Zimbabwe, published today.
Recently, a team of researchers from the King's College London, Guy's and St Thomas' NHS Foundation Trust, and St Thomas' Hospital, London analyzed comprehensive epidemiological and viral nanopore sequence data from 574 patients with SARS-CoV-2 infection confirmed by a PCR test in March 2020.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $754,000 from the closing of the third and final tranche of a non-brokered private placement of 430,713 units priced at $1.75 per Unit.
A new public-private partnership between the National Science Foundation (NSF), National Cancer Institute (NCI), Stand Up To Cancer (SU2C) and The V Foundation for Cancer Research is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Interventions that target individuals with a high risk of contracting HIV have a negligible impact on HIV transmission in the general population, according to a new study of communities in Zimbabwe, published today.
Recently, a team of researchers from the King's College London, Guy's and St Thomas' NHS Foundation Trust, and St Thomas' Hospital, London analyzed comprehensive epidemiological and viral nanopore sequence data from 574 patients with SARS-CoV-2 infection confirmed by a PCR test in March 2020.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $754,000 from the closing of the third and final tranche of a non-brokered private placement of 430,713 units priced at $1.75 per Unit.
A new public-private partnership between the National Science Foundation (NSF), National Cancer Institute (NCI), Stand Up To Cancer (SU2C) and The V Foundation for Cancer Research is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Donald Bailey, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (435) 864-2708 | Jacob Donald Bailey, MD 130 White Sage Ave, Delta, UT 84624-8928 Ph: (435) 864-2708 |
News Archive
Interventions that target individuals with a high risk of contracting HIV have a negligible impact on HIV transmission in the general population, according to a new study of communities in Zimbabwe, published today.
Recently, a team of researchers from the King's College London, Guy's and St Thomas' NHS Foundation Trust, and St Thomas' Hospital, London analyzed comprehensive epidemiological and viral nanopore sequence data from 574 patients with SARS-CoV-2 infection confirmed by a PCR test in March 2020.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $754,000 from the closing of the third and final tranche of a non-brokered private placement of 430,713 units priced at $1.75 per Unit.
A new public-private partnership between the National Science Foundation (NSF), National Cancer Institute (NCI), Stand Up To Cancer (SU2C) and The V Foundation for Cancer Research is committing $11.5 million towards transformational, theoretical biophysics that could have a significant impact on cancer research and treatment.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
› Verified 8 days ago
Steven W Shamo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 White Sage Ave, Delta, UT 84624 Phone: 435-864-3333 Fax: 435-864-2790 | |
Sonja L. Cazier, APRN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 140 White Sage Ave, Delta, UT 84624 Phone: 435-864-3333 Fax: 435-864-2790 | |
Alan Ross Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 White Sage Ave, Delta, UT 84624 Phone: 435-864-3333 Fax: 435-864-2790 | |
Joshua Arjaan Dekker, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 White Sage Ave, Delta, UT 84624 Phone: 435-864-2708 Fax: 435-864-2855 | |
Dr. Rhett Foster Crapo, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 White Sage Ave, Delta, UT 84624 Phone: 435-864-2708 |